Vaccines
Vaccines
Filter Total Items: 4
White-nose syndrome vaccine update and research on host protection mechanisms
Sixteen years after Pd, the fungus that causes white-nose syndrome in bats, was first recognized in New York, its range now extends to the Rocky Mountains, and it has been definitively detected in all but seven states (Alaska, Arizona, Florida, Hawaii, Nevada, Oregon, and Utah). The National Wildlife Health Center and our partners continue to field test a WNS vaccine for wild bats and to research...
Field trials for testing of white-nose syndrome vaccine candidates
White-nose syndrome (WNS), caused by the fungus Pseudogymnoascus destructans (Pd), continues to decimate bat populations in North America, and efforts to develop treatment options have intensified. One potential method for controlling WNS is vaccination of bats with specific antigens to elicit a protective immune response.
Development of SARS-CoV-2 vaccine to support black-footed ferret conservation
The SARS-CoV-2 virus is known to infect and cause severe disease, such as respiratory distress and death, in mustelids, including farm-raised mink ( Mustela lutreola and Neovison vison ) and domestic ferrets ( M. putorius ). This raised concern that the virus may also pose a threat to endangered black-footed ferrets ( Mustela nigripes ) managed in captivity for breeding and recovery purposes.
Vaccines
The USGS National Wildlife Health Center (NWHC) works on developing various disease management tools, including the development of vaccines. Our current work focuses on vaccines for sylvatic plague, white-nose syndrome, and rabies as disease control strategies.